These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 25975811)
1. Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndrome. Varettoni M; Marchioni E; Bonfichi M; Picchiecchio A; Arcaini L; Arbasino C; Gotti M; Da Vià M; Delmonte M; Sciarra R; Cazzola M Am J Hematol; 2015 Aug; 90(8):E152-3. PubMed ID: 25975811 [No Abstract] [Full Text] [Related]
2. The Case ∣ Hyperbicarbonatemia in a patient with Waldenstrom's macroglobulinemia. Pseudohyperbicarbonatemia due to paraproteinemia. Krish P; Jhaveri KD Kidney Int; 2012 Mar; 81(6):603-5. PubMed ID: 22373713 [No Abstract] [Full Text] [Related]
3. Successful treatment of Bing-Neel syndrome using intrathecal chemotherapy and systemic combination chemotherapy followed by BEAM auto-transplant: a case report and review of literature. Abdallah AO; Atrash S; Muzaffar J; Abdallah M; Kumar M; Van Rhee F; Barlogie B Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):502-6. PubMed ID: 23747080 [No Abstract] [Full Text] [Related]
4. [Successful treatment of Bing-Neel syndrome using combination therapy with fludarabine and rituximab]. Nagaharu K; Miyazami K; Imai H; Tamura A; Umino A; Fujieda A; Sugimoto Y; Yamaguchi M; Masuya M; Katayama N Rinsho Ketsueki; 2014 Dec; 55(12):2423-8. PubMed ID: 25744044 [TBL] [Abstract][Full Text] [Related]
5. [Pathology, diagnostics, and treatment of Waldenström's macroglobulinaemia]. Holmström MO Ugeskr Laeger; 2011 Oct; 173(41):2557-60. PubMed ID: 21985832 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic experience of Bing-Neel Syndrome associated with Waldenstrom's macroglobulinemia. Kim HD; Shin KC; Cho HS; Kim MK; Lee KH; Hyun MS J Korean Med Sci; 2007 Dec; 22(6):1079-81. PubMed ID: 18162727 [TBL] [Abstract][Full Text] [Related]
7. Standard Dose of Ibrutinib is Effective in the Treatment of Bing-Neel Syndrome. Plander M; Szendrei T; Vadvári Á; Iványi J Pathol Oncol Res; 2020 Jan; 26(1):591-592. PubMed ID: 30357751 [No Abstract] [Full Text] [Related]
9. Bendamustine therapy in patients with relapsed or refractory Waldenström's macroglobulinemia. Treon SP; Hanzis C; Tripsas C; Ioakimidis L; Patterson CJ; Manning RJ; Sheehy P Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):133-5. PubMed ID: 21454214 [TBL] [Abstract][Full Text] [Related]
10. Alkylating Agents in the Treatment of Waldenström Macroglobulinemia. Buske C Hematol Oncol Clin North Am; 2018 Oct; 32(5):821-827. PubMed ID: 30190020 [TBL] [Abstract][Full Text] [Related]
11. Selective loss of lymphoid component simulating myeloma in lymphoplasmacytic lymphoma treated with rituximab. O'Connor SR; Rana SK Br J Haematol; 2013 May; 161(4):460. PubMed ID: 23530469 [No Abstract] [Full Text] [Related]
12. Waldenstrom's macroglobulinaemia: to treat or not to treat? Sundriyal D; Kumar N; Kotwal S; Shirsi N BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25414220 [TBL] [Abstract][Full Text] [Related]